| 01/07 | GLYCOMIMETICS : Drug Candidate For Acute Myeloid Leukemia Gets Chinese Regulator.. | MT |
| 2020 | GLYCOMIMETICS : New Supportive Efficacy Data for GlycoMimetics' Rivipansel in Si.. | BU |
| 2020 | Roth Capital Adjusts GlycoMimetics' Price Target to $15 From $9, Reiterates B.. | MT |
| 2020 | GLYCOMIMETICS : Uproleselan in Combination with Venetoclax HMA Shown to Break Ch.. | AQ |
| 2020 | GLYCOMIMETICS : ' Uproleselan in Combination With Venetoclax/HMA Shown to Break .. | BU |
| 2020 | GLYCOMIMETICS : to Present at Two Upcoming Virtual Healthcare Investor Conferenc.. | AQ |
| 2020 | GLYCOMIMETICS : to Present at Two Upcoming Virtual Healthcare Investor Conferenc.. | BU |
| 2020 | GLYCOMIMETICS : Reports Highlights and Financial Results for Third Quarter 2020 | AQ |
| 2020 | GLYCOMIMETICS INC : Results of Operations and Financial Condition, Financial Sta.. | AQ |
| 2020 | GLYCOMIMETICS : Reports Highlights and Financial Results for Third Quarter 2020 | BU |
| 2020 | GLYCOMIMETICS : 3Q Earnings Snapshot | AQ |
| 2020 | GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND .. | AQ |
| 2020 | GLYCOMIMETICS : Program Data to be Highlighted Via Three Oral Presentations and .. | BU |
| 2020 | GLYCOMIMETICS : to Report Third Quarter Financial Results on November 6, 2020 | AQ |
| 2020 | GLYCOMIMETICS : to Report Third Quarter Financial Results on November 6, 2020 | BU |
| 2020 | GLYCOMIMETICS : New Pediatric and Secondary Endpoint Data from Rivipansel Phase .. | AQ |
| 2020 | GLYCOMIMETICS : New Pediatric and Secondary Endpoint Data from Rivipansel Phase .. | BU |
| 2020 | GLYCOMIMETICS INC : Entry into a Material Definitive Agreement, Financial Statem.. | AQ |
| 2020 | GLYCOMIMETICS : FDA Grants GlycoMimetics Rare Pediatric Disease Designation for .. | AQ |
| 2020 | GLYCOMIMETICS : FDA Grants GlycoMimetics Rare Pediatric Disease Designation for .. | BU |
| 2020 | GLYCOMIMETICS : Apollomics, Inc. Receives China Investigational New Drug Approva.. | AQ |
| 2020 | GLYCOMIMETICS : to Present at Upcoming H.C. Wainwright & Co Annual Global Invest.. | BU |
| 2020 | GLYCOMIMETICS : Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | BU |
| 2020 | GLYCOMIMETICS : New Preclinical GlycoMimetics Data Suggests Uproleselan With Ven.. | AQ |
| 2020 | GLYCOMIMETICS : New Preclinical GlycoMimetics Data Suggests Uproleselan With Ven.. | BU |
| 2020 | GLYCOMIMETICS : Reports Highlights and Financial Results for Second Quarter 2020 | AQ |
| 2020 | GLYCOMIMETICS INC : Results of Operations and Financial Condition, Financial Sta.. | AQ |
| 2020 | GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND .. | AQ |
| 2020 | GLYCOMIMETICS : 2Q Earnings Snapshot | AQ |
| 2020 | GLYCOMIMETICS : Reports Highlights and Financial Results for Second Quarter 2020 | BU |
| 2020 | GLYCOMIMETICS : to Report Second Quarter Financial Results on July 31, 2020 | AQ |
| 2020 | GLYCOMIMETICS : to Report Second Quarter Financial Results on July 31, 2020 | BU |
| 2020 | GLYCOMIMETICS : Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | BU |
| 2020 | GLYCOMIMETICS : New Efficacy and Biomarker Data from Rivipansel Phase 3 RESET tr.. | AQ |
| 2020 | GLYCOMIMETICS : New Efficacy and Biomarker Data From Rivipansel Phase 3 RESET Tr.. | BU |
| 2020 | GLYCOMIMETICS : to Present at Upcoming Jefferies Virtual Healthcare Conference | AQ |
| 2020 | GLYCOMIMETICS : to Present at Upcoming Jefferies Virtual Healthcare Conference | BU |
| 2020 | GLYCOMIMETICS INC : Submission of Matters to a Vote of Security Holders (form 8-.. | AQ |
| 2020 | GLYCOMIMETICS : to Present New Preclinical Data Highlighting Biomarkers and Pote.. | AQ |
| 2020 | GLYCOMIMETICS : to Present New Preclinical Data Highlighting Biomarkers and Pote.. | BU |
| 2020 | GLYCOMIMETICS : Announces Change to Virtual Meeting Format for 2020 Annual Meeti.. | AQ |
| 2020 | GLYCOMIMETICS : Announces Change to Virtual Meeting Format for 2020 Annual Meeti.. | BU |
| 2020 | GLYCOMIMETICS : Reports Operational Highlights and Financial Results for First Q.. | AQ |
| 2020 | GLYCOMIMETICS INC : Results of Operations and Financial Condition, Financial Sta.. | AQ |
| 2020 | GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND .. | AQ |
| 2020 | GLYCOMIMETICS : 1Q Earnings Snapshot | AQ |
| 2020 | GLYCOMIMETICS : Reports Operational Highlights and Financial Results for First Q.. | BU |
| 2020 | GLYCOMIMETICS : Compelling Data on Mechanism of Action for GlycoMimetics Late-st.. | AQ |
| 2020 | GLYCOMIMETICS : Compelling Data on Mechanism of Action for GlycoMimetics' Late-s.. | BU |
| 2020 | GLYCOMIMETICS : to Report First Quarter Financial Results on May 1, 2020 | AQ |
| 2020 | GLYCOMIMETICS : to Report First Quarter Financial Results on May 1, 2020 | BU |
| 2020 | GLYCOMIMETICS : Appoints Dr. Myra Rosario Herrle as Vice President, Regulatory A.. | BU |
| 2020 | GLYCOMIMETICS : Reports Inducement Grant under NASDAQ Listing Rule 5635(4) | AQ |
| 2020 | GLYCOMIMETICS : Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | BU |
| 2020 | GLYCOMIMETICS : Reports Highlights and Financial Results for Fourth Quarter and .. | AQ |
| 2020 | GLYCOMIMETICS INC : Results of Operations and Financial Condition, Other Events,.. | AQ |
| 2020 | GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND .. | AQ |
| 2020 | GLYCOMIMETICS : 4Q Earnings Snapshot | AQ |
| 2020 | GLYCOMIMETICS : Reports Highlights and Financial Results for Fourth Quarter and .. | BU |
| 2020 | GLYCOMIMETICS : to Present at the Cowen and Company 40th Annual Health Care Conf.. | BU |
| 2020 | GLYCOMIMETICS INC : Termination of a Material Definitive Agreement (form 8-K) | AQ |
| 2020 | GLYCOMIMETICS : Advances GMI-1359 Program With Patent Issuance and FDA Designati.. | BU |
| 2020 | GLYCOMIMETICS : First Patient with Advanced Breast Cancer Receives First Dose in.. | AQ |
| 2020 | GLYCOMIMETICS : First Patient With Advanced Breast Cancer Receives First Dose in.. | BU |
| 2020 | GLYCOMIMETICS INC : Entry into a Material Definitive Agreement, Regulation FD Di.. | AQ |
| 2020 | GLYCOMIMETICS : and Apollomics Announce Exclusive Collaboration and License Agre.. | BU |
| 2019 | GLYCOMIMETICS : to Present at the Piper Jaffrey 31st Annual Healthcare Conferenc.. | AQ |
| 2019 | GLYCOMIMETICS : to Present at the Piper Jaffrey 31st Annual Healthcare Conferenc.. | BU |
| 2019 | GLYCOMIMETICS INC : Regulation FD Disclosure (form 8-K) | AQ |
| 2019 | GLYCOMIMETICS : to Present at Two Upcoming Investor Conferences | BU |
| 2019 | GLYCOMIMETICS : Reports Third Quarter 2019 Financial Results and Recent Operatio.. | BU |
| 2019 | GLYCOMIMETICS : to Present Further Analysis of Data From Phase 1/2 AML Trial of .. | BU |
| 2019 | GLYCOMIMETICS : to Report Third Quarter 2019 Financial Results on November 7, 20.. | BU |
| 2019 | GLYCOMIMETICS : to Present at Two Upcoming Investor Conferences | BU |
| 2019 | GLYCOMIMETICS : Reports Top-line Results From Pfizer's Phase 3 Clinical Trial Ev.. | PU |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
